Identification of serological biomarkers for diagnosis of rheumatoid arthritis using a protein array-based approach.
10.12122/j.issn.1673-4254.2022.05.15
- Author:
Yi Peng HAN
1
;
Xiao Xi LU
1
;
Wei Nan LAI
1
;
Ren Ge LIANG
1
;
Min YANG
1
;
Qing Qing OUYANG
1
Author Information
1. Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
- Publication Type:Journal Article
- Keywords:
biomarkers;
cytokine;
cytokine receptor;
protein chip;
rheumatoid arthritis
- MeSH:
Arthritis, Rheumatoid/diagnosis*;
Biomarkers;
C-Reactive Protein;
Cytokines;
Humans;
Insulin-Like Growth Factor Binding Protein 4;
Protein Array Analysis;
Receptors, Cell Surface
- From:
Journal of Southern Medical University
2022;42(5):733-739
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the cytokine patterns in patients with rheumatoid arthritis (RA) and healthy individuals and identify candidate serum biomarkers for clinical diagnosis of RA.
METHODS:This study was conducted among 59 patients diagnosed with RA in our hospital from 2015 to 2019 with 46 age- and gender-matched healthy subjects who received regular physical examinations in our hospital as the control group. Serological autoimmune profiles of 5 RA patients and 5 healthy control subjects were obtained from human cytokine microarrays. We selected 4 differentially expressed cytokines (LIMPII, ROBO3, Periostin and IGFBP-4) and 2 soluble cytokine receptors of interest (2B4 and Tie-2) and examined their serum levels using enzyme-linked immunosorbent assay in 54 RA patients and 41 healthy control subjects. Spearman correlation test was performed to assess the correlation of serum cytokine and soluble receptor expression levels with the clinical features including rheumatoid factor (RF), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), disease activity score (DAS28) and health assessment questionnaire (HAQ). Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic capability of these cytokines.
RESULTS:We identified 6 dysregulated cytokines and soluble receptors (2B4, LIMPII, Tie-2, ROBO3, periostin and IGFBP-4) in RA patients (P < 0.01). The serum levels of LIMPII, ROBO3 and periostin were significantly correlated with the disease activity indicators including RF (P < 0.001), CRP (P < 0.001), DAS28 (P < 0.001) and HAQ (P < 0.001) in RA patients. Among the 6 candidate cytokines, 2B4 showed the largest area under the curve (AUC) of 0.861 for RA diagnosis (P < 0.001), followed then by LIMPII, ROBO3, periostin, Tie-2 and IGFBP-4.
CONCLUSION:Serum levels of LIMPII, ROBO3 and periostin can be indicative of the disease activity of RA, and serum 2B4, LIMPII, periostin, ROBO3, IGFBP-4 and Tie-2 levels may serve as biomarkers for the diagnosis of RA.
